Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Mousa, SA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 133 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Abulencia, JP; Tien, N; McCarty, OJT; Plymire, D; Mousa, SA; Konstantopoulos, K
      Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    2. Sielecki, TM; Liu, J; Mousa, SA; Racanelli, AL; Hausner, EA; Wexler, RR; Olson, RE
      Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Hein, TW; Platts, SH; Waitkus-Edwards, KR; Kuo, L; Mousa, SA; Meininger, GA
      Integrin-binding peptides containing RGD produce coronary arteriolar dilation via cyclooxygenase activation

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    4. Wilson, MF; Blum, R; Dandona, P; Mousa, SA
      Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: A model of human diseases

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    5. Mousa, SA; Zhang, Q; Sitte, N; Ji, RR; Stein, C
      beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue

      JOURNAL OF NEUROIMMUNOLOGY
    6. Mousa, SA; Forsythe, MS
      Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography

      THROMBOSIS RESEARCH
    7. Bishop, GG; McPherson, JA; Sanders, JM; Hesselbacher, SE; Feldman, MJ; McNamara, CA; Gimple, LW; Powers, ER; Mousa, SA; Sarembock, IJ
      Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit

      CIRCULATION
    8. Mousa, SA; Bozarth, JM; Naik, UP; Slee, A
      Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban

      BRITISH JOURNAL OF PHARMACOLOGY
    9. Rittner, HL; Brack, A; Machelska, H; Mousa, SA; Bauer, M; Schafer, M; Stein, C
      Opioid peptide-expressing leukocytes - Identification, recruitment, and simultaneously increasing inhibition of inflammatory pain

      ANESTHESIOLOGY
    10. Kerr, JS; Slee, AM; Mousa, SA
      Small molecule alpha(v) integrin antagonists: novel anticancer agents

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Mousa, SA
      Potential role of platelet glycoprotein IIb/IIIa antagonists in cerebrovascular disorders

      CNS DRUGS
    12. Mousa, SA; Khurana, S; Forsythe, MS
      Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography - Differentiation among glycoprotein IIb/IIIa antagonists

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    13. Suich, DJ; Mousa, SA; Singh, G; Liapakis, G; Reisine, T; DeGrado, WF
      Template-constrained cyclic peptide analogues of somatostatin: Subtype-selective binding to somatostatin receptors and antiangiogenic activity

      BIOORGANIC & MEDICINAL CHEMISTRY
    14. Sielecki, TM; Wityak, J; Liu, J; Mousa, SA; Thoolen, M; Wexler, RR; Olson, RE
      Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    15. Mousa, SA; Forsythe, M; Bozarth, J; Jin, FQ; Confalone, PN
      Human platelet alpha IIb beta 3 integrin binding affinity end specificity of SJ874: antiplatelet efficacy versus aspirin

      CORONARY ARTERY DISEASE
    16. Powell, JA; Mohamed, SN; Kerr, JS; Mousa, SA
      Antiangiogenesis efficacy of nitric oxide donors

      JOURNAL OF CELLULAR BIOCHEMISTRY
    17. Walton, HL; Corjay, MH; Mohamed, SN; Mousa, SA; Santomenna, LD; Reilly, TM
      Hypoxia induces differential expression of the integrin receptors alpha(v beta 3) and alpha(v beta 5) cultured human endothelial cells

      JOURNAL OF CELLULAR BIOCHEMISTRY
    18. Mousa, MA; Mousa, SA
      Immunocytochemical studies of the gonadotropic cells in the pituitary gland of male mullet, Mugil cephalus, during the annual reproductive cycle in both natural habitat and captivity

      JOURNAL OF APPLIED ICHTHYOLOGY-ZEITSCHRIFT FUR ANGEWANDTE ICHTHYOLOGIE
    19. Mousa, SA; Machelska, H; Schafer, M; Stein, C
      Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain

      JOURNAL OF NEUROIMMUNOLOGY
    20. Mousa, SA
      Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: Implications for management of vascular disorders

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    21. Cue, D; Southern, SO; Southern, PJ; Prabhakar, J; Lorelli, W; Smallheer, JM; Mousa, SA; Cleary, PP
      A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5 beta 1-fibronectin-M1 protein complexes

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    22. Pitts, WJ; Wityak, J; Smallheer, JM; Tobin, AE; Jetter, JW; Buynitsky, JS; Harlow, PP; Solomon, KA; Corjay, MH; Mousa, SA; Wexler, RR; Jadhav, PK
      Isoxazolines as potent antagonists of the integrin alpha(v)beta(3)

      JOURNAL OF MEDICINAL CHEMISTRY
    23. Batt, DG; Petraitis, JJ; Houghton, GC; Modi, DP; Cain, GA; Corjay, MH; Mousa, SA; Bouchard, PJ; Forsythe, MS; Harlow, PP; Barbera, FA; Spitz, SM; Wexler, RR; Jadhav, PK
      Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3)

      JOURNAL OF MEDICINAL CHEMISTRY
    24. Mousa, MA; Mousa, SA
      Implication of somatolactin in the regulation of sexual maturation and spawning of Mugil cephalus

      JOURNAL OF EXPERIMENTAL ZOOLOGY
    25. Mousa, SA; Bozarth, JM; Forsythe, MS; Slee, A
      Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: Role of plasma calcium levels

      CARDIOVASCULAR RESEARCH
    26. McCarty, OJT; Mousa, SA; Bray, PF; Konstantopoulos, K
      Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions

      BLOOD
    27. Colman, RW; Jameson, BA; Lin, YZ; Johnson, D; Mousa, SA
      Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis

      BLOOD
    28. Kim, S; Bell, K; Mousa, SA; Varner, JA
      Regulation of angiogenesis in vivo by ligation of integrin alpha 5 beta 1 with the central cell-binding domain of fibronectin

      AMERICAN JOURNAL OF PATHOLOGY
    29. Mousa, SA
      Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond

      DRUG DISCOVERY TODAY
    30. Mousa, SA
      Anti-integrins as a potential therapeutic target in angiogenesis

      EXPERT OPINION ON THERAPEUTIC PATENTS
    31. Mousa, SA; Kapil, R; Mu, DX
      Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    32. Wityak, J; Tobin, AE; Mousa, SA; Wexler, RR; Olson, RE
      Isoxazoline GPIIb/IIIa antagonists bearing a phosphoramidate

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    33. Confalone, PN; Jin, FQ; Mousa, SA
      Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    34. Mousa, SA; Lorelli, W; Campochiaro, PA
      Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells

      JOURNAL OF CELLULAR BIOCHEMISTRY
    35. Kerr, JS; Wexler, RS; Mousa, SA; Robinson, CS; Wexler, EJ; Mohamed, S; Voss, ME; Devenny, JJ; Czerniak, PM; Gudzelak, A; Slee, AM
      Novel small molecule alpha v integrin antagonists: Comparative anti-cancerefficacy with known angiogenesis inhibitors

      ANTICANCER RESEARCH
    36. Mousa, SA; Lorelli, W; Mohamed, S; Batt, DG; Jadhav, PK; Reilly, TM
      alpha(v)beta(3) integrin binding affinity and specificity of SM256 in various species

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    37. Barrett, JS; Yu, J; Kapil, R; Padovani, P; Brown, F; Ebling, WF; Corjay, MH; Reilly, TM; Bozarth, JM; Mousa, SA; Pieniaszek, HJ
      Disposition and exposure of the fibrinogen receptor antagonist XV459 on alpha(IIB)beta(3), binding sites in the guinea pig

      BIOPHARMACEUTICS & DRUG DISPOSITION
    38. Olson, RE; Sielecki, TM; Wityak, J; Pinto, DJ; Batt, DG; Frietze, WE; Liu, J; Tobin, AE; Orwat, MJ; Di Meo, SV; Houghton, GC; Lalka, GK; Mousa, SA; Racanelli, AL; Hausner, EA; Kapil, RP; Rabel, HR; Thoolen, MJ; Reilly, TM; Anderson, PS; Wexler, RR
      Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action

      JOURNAL OF MEDICINAL CHEMISTRY
    39. Mousa, SA; Mousa, MA
      Immunocytochemical and histological studies on the hypophyseal-gonadal system in the freshwater Nile tilapia, Oreochromis niloticus (L.), during sexual maturation and spawning in different habitats

      JOURNAL OF EXPERIMENTAL ZOOLOGY
    40. Mousa, MA; Mousa, SA
      Immunocytochemical study on the localization and distribution of the somatolactin cells in the pituitary gland and the brain of Oreochromis niloticus(Teleostei, Cichlidae)

      GENERAL AND COMPARATIVE ENDOCRINOLOGY
    41. Machelska, H; Cabot, PJ; Mousa, SA; Zhang, Q; Stein, C
      Pain control in inflammation governed by selectins

      NATURE MEDICINE
    42. MOUSA SA; BOZARTH JM; EDWARDS S; CARROLL T; BARRETT J
      NOVEL TC-99M-LABELED PLATELET GPIIB IIIA RECEPTOR ANTAGONISTS AS POTENTIAL IMAGING AGENTS FOR VENOUS AND ARTERIAL THROMBOSIS/

      Coronary artery disease
    43. MOUSA SA; MU DX; LUCCHESI B
      RESTORATION OF CORONARY FLOW BY POTENT PLATELET GPIIB IIIA ANTAGONISTWITHOUT EXOGENOUS THROMBOLYTICS/

      The FASEB journal
    44. HANTGAN RR; MOUSA SA
      INHIBITION OF PLATELET-MEDIATED CLOT RETRACTION BY INTEGRIN ANTAGONISTS

      The FASEB journal
    45. FORSYTHE M; MOUSA SA; KHURANA S
      COMPARATIVE EFFICACY OF DIFFERENT PLATELET GPIIB IIIA RECEPTOR ANTAGONISTS ON PLATELET-MEDIATED CLOT STRENGTH USING TISSUE FACTOR-THROMBOELASTOGRAPHY/

      The FASEB journal
    46. LORELLI W; MOUSA SA; CAMPOCHIARO PA
      INTEGRINS IN HUMAN RETINAL PIGMENTED EPITHELIAL (RPE) CELLS - ROLE OFEXTRACELLULAR-MATRIX PROTEINS (ECMS) AND HYPOXIA ON THE SECRETION OF GROWTH-FACTORS

      The FASEB journal
    47. MOHAMED S; ALI S; DANDONA P; MOUSA SA
      ROLE OF ESTROGEN-RECEPTOR ON AV-BETA-3-MEDIATED CELL-ADHESION, MIGRATION AND SECRETION OF BFGF AND VEGF IN HUMAN ENDOTHELIAL AND ENDOMETRIAL CELLS

      The FASEB journal
    48. BOZARTH JM; COHEN M; MOUSA SA
      ROLE OF ALPHA-V-BETA-3 INTEGRIN IN ENDOTHELIAL AND SMOOTH-MUSCLE CELL-MIGRATION - POTENTIAL ROLE IN CORONARY-ARTERY DISEASES

      The FASEB journal
    49. MOUSA SA; FORSYTHE M; BOZARTH J; YOUSSEF A; WITYAK J; OLSON R; SIELECKI T
      XV454, A NOVEL NONPEPTIDE SMALL-MOLECULE PLATELET GIIB IIIA ANTAGONIST WITH COMPARABLE PLATELET ALPHA(IIB)BETA(3)-BINDING KINETICS TO C7E3/

      Journal of cardiovascular pharmacology
    50. MOUSA SA; OLSON RE; BOZARTH JM; LORELLI W; FORSYTHE MS; RACANELLI A; GIBBS S; SCHLINGMAN K; BOZARTH T; KAPIL R; WITYAK J; SIELECKI TM; WEXLER RR; THOOLEN MJ; SLEE A; REILLY TM; ANDERSON PS; FRIEDMAN PA
      ORAL ANTIPLATELET EFFICACY AND SPECIFICITY OF A NOVEL NONPEPTIDE PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-802/

      Journal of cardiovascular pharmacology
    51. MOUSA SA; FORSYTHE M; WITYAK J; BOZARTH J; MU DX
      INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NONPEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/

      Journal of cardiovascular pharmacology
    52. MOUSA SA; MU DX; HUSSAIN MA
      INTRANASAL ANTIPLATELET ANTITHROMBOTIC EFFICACY OF A NOVEL PLATELET GPIIB/IIIA RECEPTOR ANTAGONIST DMP755/

      Thrombosis research
    53. PEDICORD DL; THOMAS BE; MOUSA SA; DICKER IB
      GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS INHIBIT THE DEVELOPMENT OFPLATELET PROCOAGULANT ACTIVITY/

      Thrombosis research
    54. HANTGAN RR; MOUSA SA
      INHIBITION OF PLATELET-MEDIATED CLOT RETRACTION BY INTEGRIN ANTAGONISTS

      Thrombosis research
    55. MOUSA SA; BOZARTH J; YOUSSEF A; LEVINE B
      ORAL ANTIPLATELET EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP754 IN NONHUMAN-PRIMATES/

      Thrombosis research
    56. TSAO PW; FORSYTHE MS; MOUSA SA
      DISSOCIATION BETWEEN THE ANTI-AGGREGATORY AND ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN ALPHA-IIB-BETA-3 (GPIIB IIIA) ANTAGONISTS, C7E3 AND DMP728 (VOL 88, PG 137, 1997)/

      Thrombosis research
    57. MOUSA SA; SOMASUNDARAM P; SUNG BH; BOZARTH JM; LORELLI W; WILSON MF
      ELEVATION OF CIRCULATING SMOOTH-MUSCLE CELL CHEMOATTRACTANTS MITOGENSAND ENDOTHELIAL-CELL DYSFUNCTION IN CONGESTIVE-HEART-FAILURE PATIENTS- POTENTIAL ROLE OF ALPHA-V-BETA-3 INTEGRIN/

      Naunyn-Schmiedeberg's archives of pharmacology
    58. MOUSA SA; MU DX
      ANTITHROMBOTIC EFFICACY OF PLATELET GPIIB IIIA RECEPTOR ANTAGONISTS AS COMPARED TO OTHER ANTIPLATELET AND ANTICOAGULANT STRATEGIES/

      Naunyn-Schmiedeberg's archives of pharmacology
    59. MOUSA SA; BOZARTH JM; BENNETT JS
      ACTIVATION-DEPENDENT ALPHA-V-BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS VITRONECTIN AND OSTEOPONTIN

      Naunyn-Schmiedeberg's archives of pharmacology
    60. MOUSA SA; BOZARTH JM; LORELLI W; FORSYTHE MS; THOOLEN MJMC; SLEE AM; REILLY TM; FRIEDMAN PA
      ANTIPLATELET EFFICACY OF XV459, A NOVEL NONPEPTIDE PLATELET GPIIB IIAANTAGONIST - COMPARATIVE PLATELET BINDING PROFILES WITH C7E3/

      The Journal of pharmacology and experimental therapeutics
    61. MICHAELIS W; TURLAPATY P; GRAY J; FISKE WD; FAULKNER E; KORNBAUSER D; MOUSA SA
      PHARMACODYNAMICS AND PHARMACOKINETICS OF DMP-728, A PLATELET GPIIB IIIA ANTAGONIST, IN HEALTHY-SUBJECTS/

      Clinical pharmacology and therapeutics
    62. MOUSA SA; BOZARTH J; DEGRADO W; BENNETT J
      ACTIVATION-DEPENDENT ALPHA-V-BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS VITRONECTIN AND OSTEOPONTIN - POTENTIAL SURROGATE FOR MONITORING ANTI-ALPHA-V-BETA-3 INTEGRIN EFFICACY

      Circulation
    63. MOUSA SA; DEGRADO W; HARRISON D; HOLMES D; SRIVATSA SS
      DISCOVERY OF A KEY ROLE FOR THE ALPHA-NU-BETA-3 INTEGRIN IN ACUTE ANDDELAYED VASCULAR OCCLUSION AND REOCCLUSION WITHOUT EFFECTS ON HEMOSTASIS

      Circulation
    64. RABBANI R; LEBRETON H; KHURANA C; PLOW EF; MOUSA SA; LINCOFF AM
      THE ROLE OF INTEGRINS ALPHA(V)BETA(3) AND ALPHA(ILB)BETA(3) IN AN EXPERIMENTAL ARTERIAL INJURY MODEL

      Circulation
    65. VARNER JA; MOUSA SA
      ANTAGONISTS OF VASCULAR CELL INTEGRIN ALPHA-5-BETA-1 INHIBIT ANGIOGENESIS

      Circulation
    66. MOUSA SA; CHERESH DA
      RECENT ADVANCES IN CELL-ADHESION MOLECULES AND EXTRACELLULAR-MATRIX PROTEINS - POTENTIAL CLINICAL IMPLICATIONS

      Drug discovery today
    67. CORBETT JW; GRACIANI NR; MOUSA SA; DEGRADO WF
      SOLID-PHASE SYNTHESIS OF A SELECTIVE ALPHA(V)BETA(3) INTEGRIN ANTAGONIST LIBRARY

      Bioorganic & medicinal chemistry letters
    68. SRIVATSA SS; REILLY TM; HOLMES DR; SCHWARTZ RS; MOUSA SA
      COMBINED ALPHA-V-BETA-3 AND PLATELET IIB IIIA INTEGRIN BLOCKADE POTENTLY LIMITS NEOINTIMAL HYPERPLASIA AND LUMEN STENOSIS IN THE PORCINE CORONARY INJURY MODEL/

      Journal of the American College of Cardiology
    69. REILLY TM; RACANELLI AL; OLSON RE; WITYAK J; WEXLER RR; HAUSNER EA; THOOLEN MJ; MOUSA SA
      ANTIPLATELET EFFICACY OF ORALLY-ADMINISTERED DMP802, A GPIIB IIIA RECEPTOR ANTAGONIST, IN THE CONSCIOUS DOG/

      Journal of the American College of Cardiology
    70. SRIVATSA SS; TSAO P; HOLMES DR; SCHWARTZ RS; MOUSA SA
      TEMPORAL AND SPATIAL VARIATION IN ALPHA-V-BETA-3 INTEGRIN EXPRESSION FOLLOWING DEEP ARTERIAL INJURY IN THE PORCINE CORONARY RESTENOSIS MODEL

      Journal of the American College of Cardiology
    71. MOUSA SA; MU DX; HUSSAIN M
      INTRANASAL ANTIPLATELET ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB/IIIA ANTAGONIST, DMP754/

      Journal of the American College of Cardiology
    72. MOUSA SA; MU DX; REILLY TM
      INTRAVENOUS AND ORAL ANTITHROMBOTIC EFFICACY OF A NOVEL NONPEPTIDE ANTIPLATELET GPIIB IIIA ANTAGONIST, DMP-754 AS COMPARED TO OTHER ANTIPLATELET AND ANTICOAGULANT STRATEGIES/

      Thrombosis and haemostasis
    73. PEDICORD DL; MOUSA SA; DICKER IB
      PLATELET GPIIBIIIA RECEPTOR ANTAGONISTS INHIBIT PLATELET PROCOAGULANTACTIVITY

      Thrombosis and haemostasis
    74. MOUSA SA; BOZARTH J; FORSYTHE M; XUE CB; WITYAK J; OLSON R; THOOLEN M; REILLY T
      DISCOVERY OF NOVEL ORALLY-ACTIVE NONPEPTIDE ANTIPLATELET GPIIB IIIA ANTAGONIST, DMP754 - COMPARATIVE PLATELET BINDING-AFFINITY PROFILES WITH DMP728 AND C7E3/

      Thrombosis and haemostasis
    75. TSAO PW; FORSYTHE MS; MOUSA SA
      DISSOCIATION BETWEEN THE ANTI-AGGREGATORY AND ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN ALPHA(IIB)BETA(3) (GPIIB IIIA) ANTAGONISTS, C7E3 AND DMP728/

      Thrombosis research
    76. KAPIL RP; EMM TA; MOUSA SA; PADOVANI PK; QUON CY; LAM GN
      BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS/

      Thrombosis research
    77. MOUSA SA; MU DX; LUCCHESI BR
      PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/

      Stroke
    78. HUSSAIN MA; AUNGST BJ; KAPIL R; MOUSA SA
      INTRANASAL ABSORPTION OF THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP-755, AND THE EFFECT OF ANESTHESIA ON NASAL BIOAVAILABILITY/

      Journal of pharmaceutical sciences
    79. WITYAK J; SIELECKI TM; PINTO DJ; EMMETT G; SZE JY; LIU J; TOBIN AE; WANG SG; JIANG B; MA P; MOUSA SA; OLSON RE; WEXLER RR
      THE DISCOVERY OF POTENT ISOXAZOLINE GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONISTS. (VOL 40, PG 53, 1997)/

      Journal of medicinal chemistry
    80. XUE CB; WITYAK J; SIELECKI TM; PINTO DJ; BATT DG; CAIN GA; SWORIN M; ROCKWELL AL; RODERICK JJ; WANG SG; ORWAT MJ; FRIETZE WE; BOSTROM LL; LIU J; HIGLEY CA; RANKIN FW; TOBIN AE; EMMETT G; LALKA GK; SZE JY; DIMEO SV; MOUSA SA; THOOLEN MJ; RACANELLI AL; HAUSNER EA; REILLY TM; DEGRADO WF; WEXLER RR; OLSON RE
      DISCOVERY OF AN ORALLY-ACTIVE SERIES OF ISOXAZOLINE GLYCOPROTEIN IIB IIIA ANTAGONISTS/

      Journal of medicinal chemistry
    81. WITYAK J; SIELECKI TM; PINTO DJ; EMMETT G; SZE JY; LIU J; TOBIN AE; WANG SA; JIANG B; MA P; MOUSA SA; WEXLER RR; OLSON RE
      DISCOVERY OF POTENT ISOXAZOLINE GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS/

      Journal of medicinal chemistry
    82. BENNETT JS; CHAN C; VILAIRE G; MOUSA SA; DEGRADO WF
      AGONIST-ACTIVATED ALPHA-NU-BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS TO THE MATRIX PROTEIN OSTEOPONTIN

      The Journal of biological chemistry
    83. SCHAFER M; MOUSA SA; STEIN C
      CORTICOTROPIN-RELEASING FACTOR IN ANTINOCICEPTION AND INFLAMMATION

      European journal of pharmacology
    84. PEDICORD DB; THOMAS BE; MOUSA SA; DICKER IB
      PLATELET GPIIBIIIA RECEPTOR ANTAGONISTS INHIBIT PLATELET PROCOAGULANTACTIVITY

      Circulation
    85. MOUSA SA; BOZARTH JM; DEGRADO W; BENNETT JS
      ACTIVATION-DEPENDENT ALPHA-V BETA-3 ON PLATELETS AND LYMPHOCYTES BINDS VITRONECTIN AND OSTEOPONTIN

      Circulation
    86. MOUSA SA; BOZARTH JM; FORSYTHE MS; THOOLEN M; REILLY TM; WITYAK J; OLSON RE; SIELECKI TM
      XV454, A NOVEL NONPEPTIDE ANTIPLATELET AGENT WITH COMPARABLE PLATELETALPHA-IIB-BETA-3 BINDING-KINETICS TO C7E3 AND LONG-LASTING ANTIPLATELET EFFICACY AFTER SINGLE INTRAVENOUS OR ORAL-ADMINISTRATION IN NONHUMAN-PRIMATES

      Circulation
    87. SRIVATSA SS; FITZPATRICK LA; TSAO PW; REILLY TM; HOLMES DR; SCHWARTZ RS; MOUSA SA
      SELECTIVE ALPHA-V-BETA-3 INTEGRIN BLOCKADE POTENTLY LIMITS NEOINTIMALHYPERPLASIA AND LUMEN STENOSIS FOLLOWING DEEP CORONARY ARTERIAL STENTINJURY - EVIDENCE FOR THE FUNCTIONAL IMPORTANCE OF INTEGRIN ALPHA-V-BETA-3 AND OSTEOPONTIN EXPRESSION DURING NEOINTIMA FORMATION

      Cardiovascular Research
    88. MOUSA SA
      ANGIOGENESIS PROMOTERS AND INHIBITORS - POTENTIAL THERAPEUTIC IMPLICATIONS

      Molecular medicine today
    89. MOUSA SA; FORSYTHE M; LORELLI W; BOZARTH J; XUE CB; WITYAK J; SIELECKI TM; OLSON RE; DEGRADO W; KAPIL R; HUSSAIN M; WEXLER R; THOOLEN MJ; REILLY TM
      NOVEL NONPEPTIDE ANTIPLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/

      Coronary artery disease
    90. MU DX; MOUSA SA
      ANIMAL-MODEL OF ARTERIAL AND VENOUS THROMBOSIS IN DOGS - ASSESSMENT OF THE EFFICACY OF VARIOUS ANTITHROMBOTIC STRATEGIES

      The FASEB journal
    91. MOUSA SA; MU DX
      ANTITHROMBOTIC EFFICACY OF NITRIC-OXIDE DONOR IN ARTERIAL AND VENOUS THROMBOSIS MODEL IN PIGS

      The FASEB journal
    92. MOUSA SA; FORSYTHE M; REILLY TM
      PLATELET - ENDOTHELIAL-CELL INTERACTIONS IN MEDIATING THE RELEASE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1

      Biochemical archives
    93. AUNGST BJ; SAITOH H; BURCHAM DL; HUANG SM; MOUSA SA; HUSSAIN MA
      ENHANCEMENT OF THE INTESTINAL-ABSORPTION OF PEPTIDES AND NONPEPTIDES

      Journal of controlled release
    94. LUNA J; TOBE T; MOUSA SA; REILLY TM; CAMPOCHIARO PA
      ANTAGONISTS OF INTEGRIN ALPHA(V)BETA(3) INHIBIT RETINAL NEOVASCULARIZATION IN A MURINE MODEL

      Laboratory investigation
    95. BURGESS K; LIM D; MOUSA SA
      SYNTHESIS AND SOLUTION CONFORMATION OF CYCLO[RGDRGD] - A CYCLIC PEPTIDE WITH SELECTIVITY FOR THE ALPHA-V-BETA-3 RECEPTOR

      Journal of medicinal chemistry
    96. MOUSA SA; SCHAFER M; MITCHELL WM; HASSAN AHS; STEIN C
      LOCAL UP-REGULATION OF CORTICOTROPIN-RELEASING HORMONE AND INTERLEUKIN-1 RECEPTORS IN RATS WITH PAINFUL HINDLIMB INFLAMMATION

      European journal of pharmacology
    97. SRIVATSA SS; REILLY TM; HOLMES DR; SCHWARTZ RS; MOUSA SA
      SELECTIVE ALPHA-V BETA-3 INTEGRIN BLOCKADE LIMITS NEOINTIMAL HYPERPLASIA AND LUMEN STENOSIS IN THE STENTED PORCINE CORONARY-ARTERY INJURY MODEL

      Circulation
    98. RACANELLI AL; KAPIL RP; MOUSA SA; REILLY TM; THOOLEN MJ
      ORAL ANTIPLATELET EFFECTS OF DMP-754 IN DOGS AND NONHUMAN-PRIMATES

      Circulation
    99. MOUSA SA; BOZARTH J; FORSYTHE M; WITYAK J; REILLY TM; MU DX
      INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NON PEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/

      Circulation
    100. MOUSA SA; BOZARTH J; FORSYTHE M; XUE CB; WITYAK J; OLSON R; THOOLEN MJ; REILLY TM
      DISCOVERY OF A NOVEL NON PEPTIDE ANTIPLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 20:54:57